PATENT CLAIM ANALYSIS

Application Number: 15777154
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "054000"]

Abstract:
The object of the present invention is the synergistic combination of pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts thereof and hyaluronic acid and/or pharmaceutically acceptable salts thereof, for use in the treatment and/or prevention of dryness and irritation of the mucosae. A further object of the present invention are pharmaceutical compositions comprising the synergistic combination of pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts thereof and hyaluronic acid and/or pharmaceutically acceptable salts thereof, and at least one physiologically acceptable excipient, and the use of such compositions in the treatment and/or prevention of dryness and irritation of the mucosae.

Claim (Index 18):
The method of  claim 16 , wherein the pharmaceutical formulation is administered from 1 to 3 times a day.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 93.0
- Lexical Diversity: 2.45455
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15558524', '09538829', '10378371', '11492568', '12601113']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7637044094029503
- 35 USC 102 Novelty (BERT): 0.5078509382110479
- Combined Prediction Score: 0.73811906228376
- Mean Citation Score: 193.311062
- Max Citation Score: 242.51028
- Similarity Product: 157.81441302972794

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test